RGS 0.00% 12.0¢ regeneus ltd

re: Ann: Presentation at BBY Life Sciences Co... With few...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,624 Posts.
    lightbulb Created with Sketch. 141
    re: Ann: Presentation at BBY Life Sciences Co... With few companies operating in the regenerative stem cell space that are listed on global markets, Proactive Investors expects investors will twig to the growth story that is Regeneus.

    Given Regeneus’s impressive product pipeline, it is a matter of time.


    http://beforeitsnews.com/financial-markets/2013/10/regeneus-extends-reach-of-hiqcell-stem-cell-therapy-to-melbourne-2626790.html
 
watchlist Created with Sketch. Add RGS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.